Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001902665 | SCV002153569 | likely benign | Jeune thoracic dystrophy; Nephronophthisis | 2023-12-22 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002490121 | SCV002786392 | uncertain significance | Asphyxiating thoracic dystrophy 4; Nephronophthisis 12 | 2022-03-26 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004734317 | SCV005341878 | likely benign | TTC21B-related disorder | 2024-08-06 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |